Comparison of SpO₂ (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Unmatched kernel density function diagram. by Yanling Li (269030)

Subjects:

(A) Mobility rate, (B) Explored areas, (5C) Immobility time, (D) Frozen events for hole board test. by Hammad Ismail (4227988)

Dataset (Figs 2–5). by Xianyong Wang (22601067)

“…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …”

Schematic diagram of soil sample collection. by Xianyong Wang (22601067)

“…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …”

Changes in the neutrophil count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the platelet count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the white blood cell count. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Changes in the hemoglobin. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

General clinical data of 88 patients with NPC. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

CONSORT participant flow diagram. by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

S4 File - by Lu Yang (30847)

“…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…”

Source data - by Desheng Xie (21439869)

Subjects:

Innovation and night light in large and small cities. by Saul Estrin (8629173)

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. by Hala Tamim El Jarkass (16625309)

Subjects:

Significant Wilcoxon test results of the Task 1 Nasa TLX data, differences between feedback ON and OFF. by Mucahit Gemici (21519313)

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

Subjects:

Probability of Cost-Effectiveness Across CET. by Yiping An (20609789)

Subjects: